CDSCO UID IMP/IVD/2023/000104_c663bc724ee033b9fb40e9aa760be837_13b5668083c24479482c5e77bfd3a17aBeta Human Chorionic Gonadotropin (Beta Human Chorionic Gonadotropin )
- UID
- IMP/IVD/2023/000104_c663bc724ee033b9fb40e9aa760be837_13b5668083c24479482c5e77bfd3a17a
- Device class
- Class B
- Brand name
- CLIA
- License holder
- M/s. Peerless Biotech Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- Beta Human Chorionic Gonadotropin (CLIA) is a Chemiluminescence Immunoassay test for the quantitative measurement of circulating Beta Human Chorionic Gonadotropin (CLIA) in human serum or plasma, which is intended as an aid to diagnosis of ectopic pregnancy and early pregnancy
Beta Human Chorionic Gonadotropin (Beta Human Chorionic Gonadotropin ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000104_c663bc724ee033b9fb40e9aa760be837_13b5668083c24479482c5e77bfd3a17a. This device is marketed under the brand name CLIA. The license holder is M/s. Peerless Biotech Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.